Heart failure guidelines: What you need to know about the 2017 focused update

Research output: Contribution to journalReview article

Abstract

The 2017 focused update of the 2013 ACC/AHA guideline on heart failure contains new and important recommendations on prevention, novel biomarker uses, heart failure with preserved ejection fraction (HFpEF), and comorbidities such as hypertension, iron deficiency, and sleep-disordered breathing. Potential implications for management of acute decompensated heart failure will also be explored.

Original languageEnglish (US)
Pages (from-to)123-139
Number of pages17
JournalCleveland Clinic journal of medicine
Volume86
Issue number2
DOIs
StatePublished - Feb 1 2019

Fingerprint

Heart Failure
Guidelines
Sleep Apnea Syndromes
Comorbidity
Iron
Biomarkers
Hypertension

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{c80bbea0385147c09f7fe4f822d9e425,
title = "Heart failure guidelines: What you need to know about the 2017 focused update",
abstract = "The 2017 focused update of the 2013 ACC/AHA guideline on heart failure contains new and important recommendations on prevention, novel biomarker uses, heart failure with preserved ejection fraction (HFpEF), and comorbidities such as hypertension, iron deficiency, and sleep-disordered breathing. Potential implications for management of acute decompensated heart failure will also be explored.",
author = "Lee Haselhuhn and Daniel Brotman and Wittstein, {Ilan S}",
year = "2019",
month = "2",
day = "1",
doi = "10.3949/ccjm.86a.18022",
language = "English (US)",
volume = "86",
pages = "123--139",
journal = "Cleveland Clinic Journal of Medicine",
issn = "0891-1150",
publisher = "Cleveland Clinic Educational Foundation",
number = "2",

}

TY - JOUR

T1 - Heart failure guidelines

T2 - What you need to know about the 2017 focused update

AU - Haselhuhn, Lee

AU - Brotman, Daniel

AU - Wittstein, Ilan S

PY - 2019/2/1

Y1 - 2019/2/1

N2 - The 2017 focused update of the 2013 ACC/AHA guideline on heart failure contains new and important recommendations on prevention, novel biomarker uses, heart failure with preserved ejection fraction (HFpEF), and comorbidities such as hypertension, iron deficiency, and sleep-disordered breathing. Potential implications for management of acute decompensated heart failure will also be explored.

AB - The 2017 focused update of the 2013 ACC/AHA guideline on heart failure contains new and important recommendations on prevention, novel biomarker uses, heart failure with preserved ejection fraction (HFpEF), and comorbidities such as hypertension, iron deficiency, and sleep-disordered breathing. Potential implications for management of acute decompensated heart failure will also be explored.

UR - http://www.scopus.com/inward/record.url?scp=85061347860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061347860&partnerID=8YFLogxK

U2 - 10.3949/ccjm.86a.18022

DO - 10.3949/ccjm.86a.18022

M3 - Review article

C2 - 30742582

AN - SCOPUS:85061347860

VL - 86

SP - 123

EP - 139

JO - Cleveland Clinic Journal of Medicine

JF - Cleveland Clinic Journal of Medicine

SN - 0891-1150

IS - 2

ER -